Dov Zipori

Title: Dov Zipori: Innovator in Hematopoietic Stem Cell Expansion

Introduction

Dov Zipori is a notable inventor based in Rechovot, Israel. He has made significant contributions to the field of stem cell research, particularly in the expansion of undifferentiated hematopoietic stem cells. His innovative methods have the potential to advance medical treatments and therapies.

Latest Patents

Dov Zipori holds a patent for a method of preparing a conditioned medium from a confluent stromal cell culture. This method is crucial for expanding undifferentiated hematopoietic stem cells, thereby increasing their numbers. The process involves establishing a stromal cell culture in a stationary phase plug-flow bioreactor under continuous flow on a substrate that forms a physiologically acceptable three-dimensional network of fibers. Once the desired stromal cell density is achieved, the medium is collected, resulting in a stromal cell conditioned medium that is useful for expanding undifferentiated hematopoietic stem cells.

Career Highlights

Dov Zipori is associated with Pluristem Ltd., a company that focuses on developing cell therapies. His work at Pluristem has been instrumental in advancing the understanding and application of stem cell technology. With a patent portfolio that includes 1 patent, he continues to contribute to the field of regenerative medicine.

Collaborations

Dov has collaborated with notable colleagues such as Shoshana Merchav and Shai Meretski. Their combined expertise has fostered innovation and progress in their research endeavors.

Conclusion

Dov Zipori's contributions to the field of stem cell research exemplify the impact of innovative thinking in medicine. His patented methods for expanding hematopoietic stem cells hold promise for future therapeutic applications.